In 2Q16, $BCR's Vascular segment net sales grew 3% versus 2Q15 on an as reported basis. Urology net sales grew 15%, Oncology net sales grew 7%, and Surgical Specialties segment net sales grew 11% on an as-reported basis in the quarter.
$IART said that a tender offer by its subsidiary Integra Derma to buy all outstanding common and preferred shares of $DSCI at an offer price of $7.00 per common share, $32.00 per Series A Convertible Preferred share and $48.00 per Series B Convertible Preferred share, expired as scheduled on Feb. 22, 2017.
$TNC agreed with private equity fund Ambienta to buy IPC Group, a privately-held designer and manufacturer of commercial cleaning solutions based in Italy, in an all-cash transaction valued at about $350MM. $TNC expects the acquisition to be accretive to 2018 EPS. $TNC expects the acquisition to be completed in the 2Q17.